Provided by Tiger Trade Technology Pte. Ltd.

Titan Pharmaceuticals

4.61
0.0000
Volume:- -
Turnover:19.91M
Market Cap:6.13M
PE:-1.56
High:4.61
Open:4.61
Low:4.61
Close:4.61
52wk High:5.76
52wk Low:3.03
Shares:1.33M
Float Shares:723.50K
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.9464
EPS(LYR):-5.2347
ROE:-82.72%
ROA:-44.08%
PB:2.20
PE(LYR):-0.88

Loading ...

Apr 25, 2022

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Apr 04, 2022

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Mar 31, 2022

Correspondence

CORRESP [Cover] - Correspondence
Mar 31, 2022

Correspondence

CORRESP [Cover] - Correspondence
Mar 28, 2022

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Mar 25, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2022

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933
Feb 03, 2022

Major Issues Report

8-K - Current report
Jan 24, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 03, 2022

Major Issues Report

8-K - Current report
Dec 29, 2021

Major Issues Report

8-K - Current report
Dec 22, 2021

Major Issues Report

8-K - Current report
Dec 14, 2021

Major Issues Report

8-K - Current report
Nov 15, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 09, 2021

Major Issues Report

8-K - Current report
Oct 28, 2021

Major Issues Report

8-K - Current report
Oct 26, 2021

Major Issues Report

8-K - Current report
Aug 16, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 26, 2021

Major Issues Report

8-K - Current report